KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Receivables - Other (2016 - 2023)

Historic Receivables - Other for Merck (MRK) over the last 12 years, with Q1 2023 value amounting to $473.0 million.

  • Merck's Receivables - Other fell 3421.42% to $473.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was $473.0 million, marking a year-over-year decrease of 3421.42%. This contributed to the annual value of $511.0 million for FY2022, which is 4699.17% down from last year.
  • According to the latest figures from Q1 2023, Merck's Receivables - Other is $473.0 million, which was down 3421.42% from $511.0 million recorded in Q4 2022.
  • Merck's 5-year Receivables - Other high stood at $1.6 billion for Q2 2021, and its period low was $473.0 million during Q1 2023.
  • Moreover, its 3-year median value for Receivables - Other was $684.0 million (2022), whereas its average is $860.4 million.
  • In the last 5 years, Merck's Receivables - Other plummeted by 5950.0% in 2022 and then crashed by 3421.42% in 2023.
  • Merck's Receivables - Other (Quarter) stood at $964.0 million in 2021, then crashed by 46.99% to $511.0 million in 2022, then dropped by 7.44% to $473.0 million in 2023.
  • Its Receivables - Other was $473.0 million in Q1 2023, compared to $511.0 million in Q4 2022 and $567.0 million in Q3 2022.